I. Peszek

Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.

S. Weinstein, A. Reicin, A. Finn, 2000, Archives of internal medicine.

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

Heather B. Gonzalez, John D. Davis, Travis J. Bernardo, 2022, The Lancet Infectious Diseases.

Quality assurance of asthma clinical trials.

P. Enright, T. Reiss, Susan Lu, 2002, Controlled clinical trials.

Effect of Montelukast on Single‐Dose Theophylline Pharmacokinetics

T. Reiss, T. Sullivan, J. Schwartz, 1998, American journal of therapeutics.

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.

M. Laviolette, T. Reiss, Susan Lu, 1999, American journal of respiratory and critical care medicine.